Impact of cardiovascular disease in the obstetric population
Advances in Physiology Education · 01.06.2026 · 50 (2) · 379-383
DOI: 10.1152/advan.00298.2025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Physiology Education, erschienen am 01.06.2026. Verfasst von Emily M Hochreiner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cooper Medical School of Rowan University, Camden, New Jersey, United States. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Obesity, Pregnancy Complications, Cardiovascular, Hypertension. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Pregnancy induces substantial cardiovascular adaptations that may unmask or exacerbate underlying disease. This review highlights how chronic hypertension and obesity interact with pregnancy-related hemodynamic changes to increase cardiovascular risk. It identifies pregnancy as a critical window for early cardiovascular risk stratification and intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cooper Medical School of Rowan University, Camden, New Jersey, United States.
- Department of Anesthesiology, Cooper University Hospital, Camden, New Jersey, United States.
ORCID-Profile: Lawrence J Mulligan
Zitieren
APA
Hochreiner, E. M., Takla, T., Majewski, M., Mele, M., & Mulligan, L. J. (2026). Impact of cardiovascular disease in the obstetric population. Advances in Physiology Education, 50(2), 379-383. https://doi.org/10.1152/advan.00298.2025
Vancouver
Hochreiner EM, Takla T, Majewski M, Mele M, Mulligan LJ. Impact of cardiovascular disease in the obstetric population. Advances in Physiology Education. 2026;50(2):379-383. doi:10.1152/advan.00298.2025
BibTeX
@article{Hochreiner2026,
author = {Hochreiner, Emily M and Takla, Tina and Majewski, Marta and Mele, Michele and Mulligan, Lawrence J},
title = {Impact of cardiovascular disease in the obstetric population},
journal = {Advances in Physiology Education},
year = {2026},
volume = {50},
number = {2},
pages = {379--383},
doi = {10.1152/advan.00298.2025}
}
EUVIMED